 |
7 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- pateclizumab (RG7416) / Roche
Trial completion, Combination therapy: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis (clinicaltrials.gov) - Feb 9, 2014
P2, N=211, Completed, Sponsor: Genentech
Active, not recruiting --> Completed
- pateclizumab (RG7416) / Roche
Enrollment change, Combination therapy: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis (clinicaltrials.gov) - May 21, 2013
P2, N=211, Completed, Sponsor: Genentech
Active, not recruiting --> Completed N=210210 --> 211